(Q46657712)

24 December 2017

title

Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus (English)

1 reference

24 December 2017

0 references

1 reference

1 reference

Southgate GS

1

1 reference

24 December 2017

Daya S

series ordinal

2

1 reference

24 December 2017

Potgieter B

series ordinal

3

1 reference

24 December 2017

publication date

1 June 1998

1 reference

24 December 2017

Journal of Chemical Neuroanatomy

published in

1 reference

24 December 2017

volume

14

1 reference

24 December 2017

issue

3-4

1 reference

24 December 2017

page(s)

151-156

1 reference

24 December 2017

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Central melatonin receptors: implications for a mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

A review of the evidence supporting melatonin's role as an antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

The melatonin message: duration versus coincidence hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Differential vulnerability of central neurons of the rat to quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Excitotoxicity and motor neurone disease: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

Identification of quinolinic acid in rat and human brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2898%2900026-X

7 January 2021

10.1016/S0891-0618(98)00026-X

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017